Ineffectiveness of <i>Lactobacillus johnsonii</i> LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial

Marteau, Philippe; Lémann, Marc; Seksik, Philippe; Laharie, David; Colombel, J.F.; Bouhnik, Yoram; Cadiot, Guillaume; C Soulé, J; Bourreille, Arnaud; Metman, Edouard-Henri; Lerebours, Éric; Carbonnel, F.; Louis Dupas, Jean; Veyrac, M; Coffin, Benoît; Moreau, J.; Abitbol, Véred; Blum-Sperisen, Stephanie; Y. Mary, J.

doi:10.1136/gut.2005.076604

Public

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial

Published in Gut • Dec 23, 2005

Authors:

Philippe Marteau

Marc Lémann

Philippe Seksik

Abstract

BACKGROUND AND AIMS: Early endoscopic recurrence is frequent after intestinal resection for Crohn's disease. Bacteria are involved, and probiotics may modulate immune responses to the intestinal flora. Here we tested the probiotic strain Lactobacillus johnsonii LA1 in this setting. PATIENTS AND METH...

Subject

Crohn's disease

Placebo

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!